These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29544749)

  • 1. Clinical utility of bone turnover markers in the management of common metabolic bone diseases in adults.
    Glendenning P; Chubb SAP; Vasikaran S
    Clin Chim Acta; 2018 Jun; 481():161-170. PubMed ID: 29544749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis.
    Vasikaran SD; Miura M; Pikner R; Bhattoa HP; Cavalier E;
    Calcif Tissue Int; 2023 Feb; 112(2):148-157. PubMed ID: 34846540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis.
    Vasikaran SD; Chubb SA
    Endocrine; 2016 May; 52(2):222-5. PubMed ID: 26906711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.
    Greenblatt MB; Tsai JN; Wein MN
    Clin Chem; 2017 Feb; 63(2):464-474. PubMed ID: 27940448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis.
    Camacho PM; Lopez NA
    Clin Chem Lab Med; 2008; 46(10):1345-57. PubMed ID: 18844486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of bone remodelling in metabolic bone disease.
    de Vernejoul MC
    Drugs Aging; 1998; 12 Suppl 1():9-14. PubMed ID: 9673861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Bone-Turnover Markers in Asia-Pacific Populations.
    Vasikaran S; Thambiah SC; Tan RZ; Loh TP;
    Ann Lab Med; 2024 Mar; 44(2):126-134. PubMed ID: 37869778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis.
    Brouwers P; Bouquegneau A; Cavalier E
    Curr Opin Endocrinol Diabetes Obes; 2024 Aug; 31(4):149-156. PubMed ID: 38804196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of bone turnover markers in patients with chronic kidney disease.
    Smout D; Jørgensen HS; Cavalier E; Evenepoel P
    Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):332-338. PubMed ID: 35703216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement and Clinical Utility of βCTX in Serum and Plasma.
    Chubb SAP; Vasikaran SD
    Adv Clin Chem; 2017; 81():97-134. PubMed ID: 28629592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
    Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
    Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of biochemical markers in the management of osteoporosis.
    Henriksen K; Christiansen C; Karsdal MA
    Climacteric; 2015; 18 Suppl 2():10-8. PubMed ID: 26507704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Utility of bone turnover markers in metabolic bone disease detection in patients with phenylketonuria].
    Mirás A; Freire Corbacho A; Rodríguez García J; Leis R; Aldámiz-Echevarría L; Fraga JM; Couce ML
    Med Clin (Barc); 2015 Mar; 144(5):193-7. PubMed ID: 24559543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards optimising the provision of laboratory services for bone turnover markers.
    Vasikaran SD; Chubb SA; Schneider HG
    Pathology; 2014 Jun; 46(4):267-73. PubMed ID: 24798169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Turnover Markers: Basic Biology to Clinical Applications.
    Schini M; Vilaca T; Gossiel F; Salam S; Eastell R
    Endocr Rev; 2023 May; 44(3):417-473. PubMed ID: 36510335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone turnover markers: Emerging tool in the management of osteoporosis.
    Shetty S; Kapoor N; Bondu JD; Thomas N; Paul TV
    Indian J Endocrinol Metab; 2016; 20(6):846-852. PubMed ID: 27867890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers of bone turnover in children with clinical bone fragility.
    Bowden SA; Akusoba CI; Hayes JR; Mahan JD
    J Pediatr Endocrinol Metab; 2016 Jun; 29(6):715-22. PubMed ID: 27049615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
    Eastell R; Pigott T; Gossiel F; Naylor KE; Walsh JS; Peel NFA
    Eur J Endocrinol; 2018 Jan; 178(1):R19-R31. PubMed ID: 29046326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.